| Naslov: | FoxP3+ regulatory T-cell quantities in nodal T-follicular helper cell lymphomas and peripheral T-cell lymphomas not otherwise specified and their impact on overall survival |
|---|
| Avtorji: | ID Erzar, Eva (Avtor)
ID Tzankov, Alexandar (Avtor)
ID Ocvirk, Janja (Avtor)
ID Grčar-Kuzmanov, Biljana (Avtor)
ID Boltežar, Lučka (Avtor)
ID Kloboves-Prevodnik, Veronika (Avtor)
ID Gašljević, Gorana (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2072-6694/16/23/4011
 PDF - Predstavitvena datoteka, prenos (3,45 MB)
MD5: 77985348199F13D9E79E38172AD1EC4D
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  OI - Onkološki inštitut Ljubljana
|
|---|
| Povzetek: | The role of FoxP3+ regulatory T cells (Tregs) in the tumour microenvironment (TME) of peripheral T-cell lymphomas (PTCLs) is complex, and their impact on overall survival (OS) is unclear. This retrospective study aims to examine the quantity of FoxP3+ cells in the TME of PTCLs and reactive lymph nodes (LNs) and their impact on OS. A lower FoxP3+ cell quantity is found in PTCLs compared to reactive LNs. While differences in OS are observed between groups with high and low FoxP3+ cell quantities using various cut-off values, further analyses show no significant impact on the risk of death. This study suggests FoxP3+ cells as potential prognostic biomarkers but recommends the conduction of larger, multicentre studies with standardized protocols for confirmation. It also indicates that Treg-suppressing drugs may not be suitable for certain PTCL patients. Instead, combining therapies, including those enhancing Treg function, could be more effective in improving outcomes for PTCL patients, warranting further research. |
|---|
| Ključne besede: | lymphoma, prognostic biomarkers, overall survival |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 28.09.2024 |
|---|
| Datum sprejetja članka: | 25.11.2024 |
|---|
| Datum objave: | 29.11.2024 |
|---|
| Kraj izida: | Basel |
|---|
| Založnik: | MDPI |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 4011-1-4011-15 |
|---|
| Številčenje: | Vol. 16, iss. 23 |
|---|
| Izvor: | Basel, Switzerland |
|---|
| PID: | 20.500.12556/DiRROS-21161  |
|---|
| UDK: | 616-07 |
|---|
| ISSN pri članku: | 2072-6694 |
|---|
| DOI: | 10.3390/cancers16234011 |
|---|
| COBISS.SI-ID: | 217313539 |
|---|
| Avtorske pravice: | by Authors |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 14. 11. 2024;
|
|---|
| Datum objave v DiRROS: | 09.01.2025 |
|---|
| Število ogledov: | 21 |
|---|
| Število prenosov: | 9 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
